BiomX Inc. 8-K

What Happened

• BiomX Inc. filed an 8-K reporting that on March 4, 2026, Jonathan Solomon resigned as Chief Executive Officer, Chief Principal Officer and as a director, and Dr. Russell Greig resigned as Chairman and as a director. The company stated both resignations were not due to any disagreement with the company’s operations, policies or practices.
• On the same date the Board appointed Michael Oster (age 54) as Chief Executive Officer, effective March 4, 2026. The company and Mr. Oster have not yet entered into any compensatory arrangement.
• Also on March 4, 2026 the Board appointed Amir Shalom (age 45) as a Class I director, with a term expiring at the 2027 annual meeting; the Board determined he is independent under NYSE American rules. The Board will enter into its standard indemnification agreement with Mr. Shalom and will pay him the company’s usual prorated director cash fees.

Key Details

• Resignations effective March 4, 2026: Jonathan Solomon (CEO, CPO, director) and Dr. Russell Greig (Chairman, director); both resignations not due to disagreements.
• CEO appointment: Michael Oster appointed CEO effective March 4, 2026; no compensation agreement disclosed as of the 8‑K.
• Director appointment: Amir Shalom appointed Class I director (term through 2027 annual meeting); will receive prorated standard director fees and an indemnification agreement.
• Board committee changes effective March 5, 2026: Audit Committee — Liat Bidas (Chair), Guy Arieli, Shaked Ran; Compensation Committee — Amir Shalom (Chair), Guy Arieli; Nominating & Corporate Gov. Committee — Liat Bidas (Chair), Guy Arieli, Shaked Ran.

Why It Matters

• This 8-K documents a clear leadership and board transition: both the CEO and Chairman positions turned over in early March 2026, and replacements were named immediately.
• The filing notes no disagreements caused the departures and no CEO compensation has been announced, so investors should expect future filings or disclosures detailing Mr. Oster’s terms and any strategic plans tied to the leadership change.
• Updated committee memberships and an independent new director (Amir Shalom) change board oversight composition, which is material to governance and oversight of company strategy and operations.